Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 3.5T | 3.7T | 3.5T |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 15.3B | 15.2B | 13.9B |
Other operating expenses | — | 200.6B | 192.9B | 158.3B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 42.0B | 62.5B | 50.0B |
Other income expense | — | 823.4B | -288.0B | 347.0B |
Pretax income | 273.0B | -95.4B | 286.7B | 459.4B |
Tax provision | 69.1B | -12.6B | 74.5B | 111.6B |
Net income | 203.9B | -82.7B | 212.3B | 347.7B |
Basic EPS | 2.6K | — | 2.7K | 4.4K |
Diluted EPS | 2.6K | — | 2.7K | 4.4K |
Basic average shares | — | — | 78.4M | 78.4M |
Diluted average shares | — | — | 78.4M | 78.4M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | -82.7B | 212.3B | 171.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |